Insights

Acquisition Opportunity Johnson & Johnson MedTech’s acquisition of V-Wave positions the combined entity to accelerate adoption of heart failure technologies. A proactive outreach to J&J MedTech and its portfolio managers could open co-selling or licensing discussions, especially around RELIEVE-HF data utilization and integration with J&J’s existing cardiac platforms.

Strategic Expansion V-Wave’s focus on interatrial shunt devices for severe heart failure aligns with growing demand for minimally invasive solutions. Market-entry opportunities exist for partnerships with hospitals and health systems seeking innovative HF therapies, as well as with distributors looking to expand advanced cardiac device offerings.

Technology Leverage The tech stack indicates a modern, cloud-based, data-driven approach. Opportunities exist to propose integrated digital solutions, such as remote monitoring, data analytics, and regulatory-compliant patient engagement platforms that complement V-Wave’s devices and support post-market outcomes.

Clinical Evidence Momentum RELIEVE-HF pivotal data presentation signals ongoing clinical validation. There is a sales opening to engage clinicians and procurement teams with compelling trial outcomes, real-world evidence programs, and payer value demonstrations to accelerate adoption post-regulatory milestones.

Growth Readiness With substantial reported funding and a recent transformative acquisition, there is potential for channel and manufacturing scale partnerships. Exploring manufacturing collaborations, supply chain co-ops, and regional distribution alliances could support rapid market expansion and risk diversification for buyers.

Similar companies to V-Wave

V-Wave Tech Stack

V-Wave uses 8 technology products and services including HubSpot Analytics, Amazon Web Services, Drupal, and more. Explore V-Wave's tech stack below.

Media & News

V-Wave's Email Address Formats

V-Wave uses at least 2 email formats:
V-Wave Email FormatsExamplePercentage
First@vwavemedical.comJohn@vwavemedical.com
91%
First.Last@vwavemedical.comJohn.Doe@vwavemedical.com
9%

Frequently Asked Questions

What is V-Wave's official website and social media links?

Minus sign iconPlus sign icon
V-Wave's official website is vwavemedical.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does V-Wave generate?

Minus sign iconPlus sign icon
As of October 2026, V-Wave's annual revenue is estimated to be $1M - $10M.

What is V-Wave's NAICS code?

Minus sign iconPlus sign icon
V-Wave's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does V-Wave have currently?

Minus sign iconPlus sign icon
As of October 2026, V-Wave has approximately 36 employees across 3 continents, including Asia, North America and Europe. Key team members include Vp R&d: L. R., Vp Quality Assurance: G. T. and President: E. R. Explore V-Wave's employee directory with LeadIQ.

What industry does V-Wave belong to?

Minus sign iconPlus sign icon
V-Wave operates in the Medical Equipment Manufacturing industry.

What technology does V-Wave use?

Minus sign iconPlus sign icon
V-Wave's tech stack includes HubSpot Analytics, Amazon Web Services, Drupal, WordPress, Cookiebot, Adobe Experience Cloud, Microsoft 365 and Cisco.

What is V-Wave's email format?

Minus sign iconPlus sign icon
V-Wave's email format typically follows the pattern of First@vwavemedical.com. Find more V-Wave email formats with LeadIQ.

How much funding has V-Wave raised to date?

Minus sign iconPlus sign icon
As of October 2026, V-Wave has raised $226M in funding. The last funding round occurred on Dec 16, 2021 for $98M.
V-Wave logo

V-Wave

Medical Equipment ManufacturingHaifa, Israel11-50 Employees

V-Wave is a medical equipment manufacturer based in Haifa, Israel, focused on device-based therapies for heart failure and related conditions. Historically, the company pursued minimally invasive interatrial shunt devices intended to treat patients with severe symptomatic heart failure and pulmonary arterial hypertension. With a relatively small to mid-sized team, V-Wave operates within the cardiovascular segment of the medical devices industry.

In 2024, Johnson & Johnson acquired V-Wave, and the company is now part of Johnson & Johnson MedTech. The arrangement places V-Wave's research and development within a large global platform serving clinicians and health systems seeking new treatment options for advanced heart failure and related conditions.

Section iconCompany Overview

NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Employees
11-50

Section iconFunding & Financials

  • $226M

    V-Wave has raised a total of $226M of funding over 5 rounds. Their latest funding round was raised on Dec 16, 2021 in the amount of $98M as a Series C.

  • $1M - $10M

    V-Wave's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.